BiotechTube
Image Analysis Group

Image Analysis Group

London, United Kingdom· Est.
ia-grp.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12M

Overview

Image Analysis Group (IAG) is a UK-based imaging CRO that has established itself as a key service provider for pharmaceutical and biotech clinical trials since 2007. Its core offering combines a proprietary AI-powered platform, DYNAMIKA, with deep therapeutic area expertise in radiology to standardize and accelerate image-based trial endpoints. IAG operates as a service business, helping sponsors design trials, manage imaging data, and generate regulator-ready analysis across a wide range of therapeutic areas, with a particular strength in musculoskeletal disorders. The company's value proposition centers on compliance, precision, and speed in turning medical images into quantitative clinical evidence.

MusculoskeletalOncologyObesity and Metabolic DiseasesAutoimmune DiseasesRare DiseasesNeuro-Imaging

Technology Platform

DYNAMIKA AI platform for centralized clinical trial image management, workflow, and quantitative analysis, compliant with FDA, ISO, and other regulatory standards.

Funding History

1
Total raised:$12M
Series A$12M

Opportunities

The growing demand for quantitative imaging biomarkers in clinical trials, especially in complex therapeutic areas like musculoskeletal and rare diseases, presents a significant opportunity.
The integration of AI into medical image analysis is a major tailwind that can enhance the speed, precision, and regulatory acceptance of imaging endpoints.

Risk Factors

Key risks include intense competition from both specialized and full-service CROs, the operational dependency on a limited pool of expert radiologist readers, and the need for continuous technological innovation to maintain the edge of the DYNAMIKA AI platform.

Competitive Landscape

IAG competes in the specialized imaging CRO segment against companies like BioClinica (now part of LabCorp), Calyx, and other niche players, as well as the imaging divisions of large, full-service CROs. Its differentiation lies in its deep therapeutic expertise, proprietary AI platform, and strong focus on regulatory compliance.

More companies in United Kingdom →